Captor Therapeutics ® Investor Relations

      Investor Relations

      Notice of reduction of shareholding interest in Company

      Publication date: 2021-05-28
      Number: RB ESPI 11/2021

      Current report no. 11/2021

      Date of preparation: 28 May 2021
      Subject: Notice of reduction of shareholding interest in Company
      Legal basis: Article 70 point 1) of the Act on Public Offering and Conditions Governing the Introduction of Financial Instruments to Organized Trading System and of Public Companies dated 29 July 2005

      The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”) informs that it received from Sylvain Cottens a notice of reduction of his shareholding to 9.98% of the total number of votes in the Company, drawn up pursuant to Article 69 sec. 1 point 2) and sec. 2 point 1) of the Act on Public Offering and Conditions Governing the Introduction of Financial Instruments to Organized Trading System and of Public Companies dated 29 July 2005.

      The notice constitutes an appendix to this report.


      Attachments: